Clal Insurance’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed 218
2025
Q3
$0 Hold
1
﹤0.01% 214
2025
Q2
$0 Hold
1
﹤0.01% 207
2025
Q1
$0 Hold
1
﹤0.01% 204
2024
Q4
$0 Sell
1
-25,608
-100% -$443K ﹤0.01% 192
2024
Q3
$574K Hold
25,609
0.01% 105
2024
Q2
$609K Sell
25,609
-9,309
-27% -$264K 0.01% 102
2024
Q1
$1.07M Sell
34,918
-8,880
-20% -$337K 0.01% 102
2023
Q4
$1.51M Sell
43,798
-3,035
-6% -$108K 0.02% 91
2023
Q3
$3.07M Sell
46,833
-6,495
-12% -$438K 0.04% 85
2023
Q2
$4.28M Hold
53,328
0.05% 95
2023
Q1
$4.39M Hold
53,328
0.07% 94
2022
Q4
$4.57M Sell
53,328
-24,378
-31% -$2.19M 0.07% 105
2022
Q3
$7.2M Hold
77,706
0.1% 98
2022
Q2
$9.54M Sell
77,706
-2,402
-3% -$282K 0.13% 91
2022
Q1
$9.36M Buy
+80,108
New +$13.3M 0.1% 99

Other funds holding DRIO

Clal Insurance's DRIO Position: Q4 2025 in Review

Clal Insurance sold out of DarioHealth (DRIO) in Q4 2025, closing a stake of 1 share.

Clal Insurance first reported a position in DRIO in Q1 2022 and held it in 15 quarters. The position peaked at $9.54M in Q2 2022. 17 funds tracked by Wall St. Rank hold DRIO as of Q4 2025.

  • Clal Insurance reported no remaining DarioHealth position as of Q4 2025 after selling out during the quarter.
  • Clal Insurance sold 1 DarioHealth share in Q4 2025.
  • Clal Insurance first reported a position in DarioHealth in Q1 2022 and held it in 15 quarters.
  • Clal Insurance's DarioHealth position peaked at $9.54M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held DarioHealth as of Q4 2025.

Based on Clal Insurance's 13F filing for Q4 2025, filed 13 Feb 2026.